Why the study?
Does insulin resistance assessed by HOMA index predict early and late mortality in nondiabetic STEMI patients undergoing PCI?
Population
253 consecutive nondiabetic patients with ST elevation myocardial infarction submitted to percutaneous…
Comparison
Insulin resistance assessed by homeostatic model… vs Patients without insulin resistance / lower HOMA…
Design
Cohort
Follow-up
long-term
Authors
Loading...
HOMA index may refine early mortality risk stratification in nondiabetic STEMI; hypothesis-generating for insulin resistance interventions.
Does insulin resistance assessed by HOMA index predict early and late mortality in nondiabetic STEMI patients undergoing PCI?
Insulin resistance is common in nondiabetic STEMI patients undergoing PCI and serves as an independent predictor of in-hospital mortality.
Lazzeri et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: